HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmetic Claim Review Should Not Make CFSAN Priority Cut – CTFA

This article was originally published in The Rose Sheet

Executive Summary

Developing a guidance determining the regulatory classification of "cosmetics" versus "drugs" would not be an appropriate use of FDA Center for Food Safety & Applied Nutrition resources, the Cosmetic, Toiletry and Fragrance Association asserts in Aug. 9 comments to the agency addressing the center's fiscal 2005 priorities

You may also be interested in...



CFSAN 2005 Priorities Include Responding To EWG Petition

Responding to a citizen petition from the Environmental Working Group requesting FDA halt the unlawful distribution of misbranded, adulterated and unlabeled cosmetics is an "A" list priority for the agency's Center for Food Safety & Applied Nutrition in fiscal 2005

CFSAN 2005 Priorities Include Responding To EWG Petition

Responding to a citizen petition from the Environmental Working Group requesting FDA halt the unlawful distribution of misbranded, adulterated and unlabeled cosmetics is an "A" list priority for the agency's Center for Food Safety & Applied Nutrition in fiscal 2005

AHA, BHA Products Are Cosmetics Based On Legal Precedent – CTFA

FDA should not address cosmetic compliance issues by reclassifying entire categories of products as drugs, the Cosmetic, Toiletry and Fragrance Association asserts in comments to the agency

Related Content

UsernamePublicRestriction

Register

RS012369

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel